Home › Funds › TANDEM CAPITAL MANAGEMENT CORP /ADV › BSX

TANDEM CAPITAL MANAGEMENT CORP /ADV position in BSX

BOSTON SCIENTIFIC CORP · Health Care

TANDEM CAPITAL MANAGEMENT CORP /ADV reported holding 37,672 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.73% of its reported portfolio and ranking #45 among its reported holdings. TANDEM CAPITAL MANAGEMENT CORP /ADV has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)37.67K sh
Reported value held$1.64M
Portfolio Weight0.73%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How TANDEM CAPITAL MANAGEMENT CORP /ADV's BSX position evolved

TANDEM CAPITAL MANAGEMENT CORP /ADV first disclosed a stake in BSX in Q3 2023 at 59,876 shares (US$3.2M). The position peaked in Q2 2025 at 53,044 shares, worth US$5.7M. Across 13 filings, TANDEM CAPITAL MANAGEMENT CORP /ADV increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 37,672 shares valued at US$1.6M — a reduction of -3,300 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 59.88K $3.16M New
Q4 2023 58.48K $3.38M Reduce
Q1 2024 58.35K $4.00M Hold
Q2 2024 57.87K $4.42M Reduce
Q3 2024 55.15K $4.62M Reduce
Q4 2024 54.55K $4.87M Reduce
Q1 2025 53.70K $5.42M Reduce
Q2 2025 53.04K $5.70M Reduce
Q3 2025 52.76K $5.15M Reduce
Q4 2025 52.69K $5.02M Hold
Q1 2026 51.17K $3.21M Reduce
Q2 2026 40.97K $1.75M Reduce
Q3 2026 37.67K $1.64M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has TANDEM CAPITAL MANAGEMENT CORP /ADV held BSX?

TANDEM CAPITAL MANAGEMENT CORP /ADV has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TANDEM CAPITAL MANAGEMENT CORP /ADV's current position in BSX?

As of Q3 2026, TANDEM CAPITAL MANAGEMENT CORP /ADV holds 37.67K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $1.64M, representing 0.73% of its reported portfolio and ranking #45.

Has TANDEM CAPITAL MANAGEMENT CORP /ADV been buying or selling BSX?

In the latest 13F filing (Q3 2026), TANDEM CAPITAL MANAGEMENT CORP /ADV reduced its position in BSX. The position peaked in Q2 2025 at 53.04K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.